MedPath

effect of post surgery platelet rich plasma on osteochondral lesions of talus

Phase 3
Conditions
osteochondral lesion of the talus.
Osteochondropathy, unspecified
M93.9
Registration Number
IRCT20230227057547N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

patients undergoing arthroscopic surgery for osteochondral talus lesions
patients older than 18 years

Exclusion Criteria

patients who did not consent
patients with previous ankle surgery
patients with previous ankle fracture
patients with foot deformities
patients using other treatments (graft etc)
coagulopathy patients
patients using anticoagulants
patients who left the study or did not continue

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AOFAS score. Timepoint: 12 months after injection. Method of measurement: history and physical examination.;VAS (Visual Analog Scale) score. Timepoint: 12 months after injection. Method of measurement: history and physical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath